1,258 followers
36 followers
RT @FrontCellDevBio: New Research: OMIXCARE: OMICS technologies solved about 33% of the patients with heterogeneous rare neuro-developmenta…
1,840 followers
79 followers
OMIXCARE: OMICS technologies solved about 33% of the patients with heterogeneous rare neuro-developmental disorders and negative exome sequencing results and identified 13% additional candidate variants. https://t.co/hiUinXnsPD https://t.co/WYAZPk2Shq